EA
ALMR

Emerald Advisers’s Alamar Biosciences ALMR Stock Holding History

Emerald Advisers’s Portfolio ALMR Stock Details ALMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.5M Buy
+647,183
New +$14.6M 0.41% 95

Other funds holding ALMR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
DACS
Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Emerald Advisers's ALMR Position: Q2 2026 in Review

Emerald Advisers opened a new position in Alamar Biosciences (ALMR) in Q2 2026: 647,183 shares worth $17.5M. The stake represents 0.41% of the portfolio and ranks #95 among its holdings.

17 funds tracked by Wall St. Rank hold ALMR as of Q2 2026.

  • Emerald Advisers held 647,183 shares of Alamar Biosciences worth $17.5M as of Q2 2026.
  • Alamar Biosciences was a new Emerald Advisers position in Q2 2026.
  • Alamar Biosciences made up 0.41% of Emerald Advisers's portfolio in Q2 2026, its #95 holding.
  • 17 funds tracked by Wall St. Rank held Alamar Biosciences as of Q2 2026.

Based on Emerald Advisers's 13F filing for Q2 2026, filed 5 Aug 2026.